title: Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey.
abstract: There are approximately 100,000 US organ transplant recipients, many with nonmelanoma skin cancers. To better understand how clinicians treat them, we e-mailed a survey to the International Transplant-Skin Cancer Collaborative and the Association of Academic Dermatologic Surgeons. Twenty-five physicians responded. The majority use topical 5-fluorouracil, cryosurgery, electrodesiccation and curettage, and surgery. We review when these modalities are used.
authors.affiliation: Division of Dermatology, Mohs Micrographic Surgery Clinic, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
authors.forename: Anna S
authors.initials: AS
authors.lastname: Clayton
authors.forename: Thomas
authors.initials: T
authors.lastname: Stasko
mesh_terms: D002280:Basal Cell Carcinoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D003452:Cryosurgery / Q000379:methods; D004598:Electrosurgery / Q000379:methods; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D019538:Health Care Surveys; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D008297:Male; D016377:Organ Transplantation; D011379:Prognosis; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D005472:Fluorouracil